Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications drug utilization physician survey intron ® europe
… pharmacist. She has experience in meta-analysis, designing physician surveys, and analysis of multiple US claims …
… for rare disease research that can help you gain orphan drug reimbursement. View this webinar where you’ll learn: …
… patient-reported outcome strategy; large scale survey development and implementation; and a thorough understanding of the Food and Drug Administration (FDA) patient-focused drug development guidance. She has expertise across a range …
Alejandro Vanegas Surveys and Observational Studies Telecommuter - USA MS, Epidemiology Columbia University Mailman School of Public Health, New York, NY BA, History New York University College of Arts and Science, New York, NY Alejandro Vanegas, MS, CPH, …
… United States, where she supported clients by working on drug utilization and safety studies, as well as provided strategic …
… parametric and nonparametric statistical models to predict drug metabolism in human. More recently he concluded an MSc … RTI-HS from health informatics specialists First DataBank Europe, where he first worked in a role involving clinical …
Share on: January 26, 2021 Please join Xabier Garcia de Albeniz for this recorded 30-minute case-study workshop on the use of causal inference methods for real-world evidence. Related Services Health Economics Market Access and Outcomes Strategy …
… outcomes (PRO) studies Reimbursement dossiers (i.e., AMCP) Survey development, evaluation and implementation Value …
… Dr. Riera has experience in clinical pharmacy, including drug distribution, central cytostatic preparation, … compounding of total parenteral nutrition, and therapeutic drug monitoring. During her PhD, Dr. Riera acquired … RTI-HS, she has provided epidemiologic support for orphan drug applications, pediatric investigational plans, and other …
… drew on current FDA recommendations for patient-focused drug development (PFDD) and other more emergent regulatory …